| 产品名称: | Legionella pneumophila |
|---|---|
| 商品货号: | TS258373 |
| <strong>Name </strong>: | Legionella pneumophila Brenner et al. 1979 |
| <strong>DSM No. </strong>: | 7513, Type strain dsm-7513 dsm7513 dsm 7513 Legionella pneumophila |
| Strain designation : | Philadelphia-1 |
| Other collection no. <br />or WDCM no. : | ATCC 33152, WDCM 00107 |
| Serovar : | 1 |
| Isolated from : | human lung tissue |
| Country : | United States of America Philadelphia |
| Date of sampling : | before 15.03.1993 |
| <strong>Nagoya Protocol Restrictions </strong>: | There are NO known Nagoya Protocol restrictions for this strain. |
| History : | |
| Genbank accession numbers : | gene for mip: AJ878849 complete genome: AE017354 |
| Cultivation conditions : | Medium 585 , microaerophilic; needs high humidity, 37°C For the solubilization of the freeze-dried pellet any standard liquid medium (e.g. M1, M220; M92; M215) can be used Incubation time: 2-3 days Complete DSMZ Media List |
| Summary and <br />additional information : | Type strain. Taxonomy/description (4887, 4889, 5002). Sequence accession no. gene for mip: AJ878849, complete genome: AE017354. Fatty acids (5024). (Medium 585, 37°C, microaerophilic; needs high humidity). For the solubilization of the freeze-dried pellet any standard liquid medium (e.g. M1, M220; M92; M215) can be used. |
| For detailed information : | BacDive - The Bacterial Diversity Metadatabase |
| Literature : | 4887, 4888, 4889, 5002, 5024 |
| Risk group : | 2 (classification according to German TRBA) |
| Restrictions : | Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz), Category A1 Australia Group Warning List, Category B1 |
| Other cultures : | All DSMZ cultures of the species |
| 产品名称: | Legionella pneumophila |
|---|---|
| 商品货号: | TS258373 |
| <strong>Name </strong>: | Legionella pneumophila Brenner et al. 1979 |
| <strong>DSM No. </strong>: | 7513, Type strain dsm-7513 dsm7513 dsm 7513 Legionella pneumophila |
| Strain designation : | Philadelphia-1 |
| Other collection no. <br />or WDCM no. : | ATCC 33152, WDCM 00107 |
| Serovar : | 1 |
| Isolated from : | human lung tissue |
| Country : | United States of America Philadelphia |
| Date of sampling : | before 15.03.1993 |
| <strong>Nagoya Protocol Restrictions </strong>: | There are NO known Nagoya Protocol restrictions for this strain. |
| History : | |
| Genbank accession numbers : | gene for mip: AJ878849 complete genome: AE017354 |
| Cultivation conditions : | Medium 585 , microaerophilic; needs high humidity, 37°C For the solubilization of the freeze-dried pellet any standard liquid medium (e.g. M1, M220; M92; M215) can be used Incubation time: 2-3 days Complete DSMZ Media List |
| Summary and <br />additional information : | Type strain. Taxonomy/description (4887, 4889, 5002). Sequence accession no. gene for mip: AJ878849, complete genome: AE017354. Fatty acids (5024). (Medium 585, 37°C, microaerophilic; needs high humidity). For the solubilization of the freeze-dried pellet any standard liquid medium (e.g. M1, M220; M92; M215) can be used. |
| For detailed information : | BacDive - The Bacterial Diversity Metadatabase |
| Literature : | 4887, 4888, 4889, 5002, 5024 |
| Risk group : | 2 (classification according to German TRBA) |
| Restrictions : | Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz), Category A1 Australia Group Warning List, Category B1 |
| Other cultures : | All DSMZ cultures of the species |